title: [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
authors.affiliation: Medizinische Klinik I, Charité, Campus Benjamin Franklin, Berlin. hans.scheruebl@charite.de
authors.forename: H
authors.initials: H
authors.lastname: Scherübl
authors.forename: L
authors.initials: L
authors.lastname: Schaaf
authors.forename: F
authors.initials: F
authors.lastname: Raue
authors.forename: S
authors.initials: S
authors.lastname: Faiss
authors.forename: M
authors.initials: M
authors.lastname: Zeitz
mesh_terms: D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017115:Catheter Ablation; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use; D015408:Gastrinoma / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007340:Insulinoma / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018761:Multiple Endocrine Neoplasia Type 1 / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D009362:Neoplasm Metastasis; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use; D009853:Omeprazole / Q000008:administration & dosage / Q000627:therapeutic use; D010166:Palliative Care; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011446:Prospective Studies; D054328:Proton Pump Inhibitors; D016032:Randomized Controlled Trials as Topic; D013004:Somatostatin / Q000031:analogs & derivatives; D013311:Streptozocin / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D015043:Zollinger-Ellison Syndrome / Q000601:surgery
chemical_list: D000897:Anti-Ulcer Agents; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D005765:Gastrointestinal Agents; D016898:Interferon-alpha; D054328:Proton Pump Inhibitors; D013004:Somatostatin; D013311:Streptozocin; D005047:Etoposide; D004317:Doxorubicin; D009853:Omeprazole; D002945:Cisplatin; D015282:Octreotide